hme

Axel Merseburger

Germany
Axel Merseburger
Axel Merseburger

Germany

Expert bio
Axel Merseburger is Professor of Urology and Chairman of the Department of Urology at University Hospital Schleswig‑Holstein, Campus Lübeck, in Lübeck, Germany. After graduating from Hannover Medical School, Hannover, Germany, in 2002, he completed his residency in surgery and urology at the Eberhard Karls University, in Tübingen, Germany, followed by a research fellowship at the Miller School of Medicine at the University of Miami, Miami, FL, USA, in 2006. He was appointed Associate Professor, in 2009, and Professor, in 2012, at Hannover Medical School. Prof. Merseburger’s research activity encompasses both molecular and clinical aspects of uro-oncology, with a specific interest in biomarkers and prognostic factors for prostate cancer, renal cell carcinoma, and transitional cell carcinoma. He is Principal Investigator for multiple phase 2 and phase 3 clinical trials. Prof. Merseburger is a member of various uro-oncology organizations, is as an advisor for the European Association of Urology (EAU) Guidelines Group for Renal Cancer, and has previously served as Chairman of the EAU Guidelines Group for Lasers and Technologies. Prof. Merseburger acts as a reviewer and editorial board member for several urology and oncology indexed journals, is Associate Editor of the World Journal of Urology, and is Editor-in-Chief of European Oncology & Haematology. He has published widely, having authored or co-authored over 200 peer-reviewed articles.
MORE INFORMATION
You can see my upcoming and previous webinars here.